Paloma Partners’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-36,901
Closed -$62.7K 863
2024
Q3
$62.7K Buy
+36,901
New +$60.6K ﹤0.01% 1064
2022
Q2
Sell
-15,186
Closed -$138K 1580
2022
Q1
$138K Buy
+15,186
New +$175K ﹤0.01% 1518
2021
Q4
Sell
-10,177
Closed -$260K 2049
2021
Q3
$260K Buy
+10,177
New +$302K 0.01% 769
2021
Q2
Sell
-15,394
Closed -$513K 2142
2021
Q1
$513K Buy
+15,394
New +$539K 0.01% 1099
2020
Q2
Sell
-43,077
Closed -$132K 2189
2020
Q1
$132K Buy
+43,077
New +$176K 0.01% 996
2019
Q4
Sell
-13,644
Closed -$70K 2405
2019
Q3
$70K Sell
13,644
-119,285
-90% -$667K ﹤0.01% 1862
2019
Q2
$804K Sell
132,929
-91,371
-41% -$641K 0.01% 799
2019
Q1
$1.62M Buy
224,300
+69,200
+45% +$500K 0.04% 525
2018
Q4
$1.15M Buy
+155,100
New +$983K 0.04% 411
2017
Q1
Sell
-26,600
Closed -$101K 2166
2016
Q4
$101K Buy
+26,600
New +$193K ﹤0.01% 1906
2015
Q1
Sell
-22,900
Closed -$180K 1373
2014
Q4
$180K Buy
22,900
+8,200
+56% +$52.5K 0.01% 1026
2014
Q3
$72K Buy
+14,700
New +$76.9K ﹤0.01% 923

Other funds holding PACB